FDA warns that compounded or repackaged drugs stored in certain syringes made by Becton-Dickinson may lose potency because of an interaction with the rubber stopper. FDA alerted healthcare ...
In a safety alert issued August 18, the FDA said compounded or repackaged drugs that have been stored in 3- and 5-mL syringes manufactured by Becton-Dickinson should not be administered to patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback